Home/Nano24med/Michael Schickler

MS

Michael Schickler

PhD

Therapeutic Areas

Immunology Respiratory Diseases Critical Care

Nano24med Pipeline

Drug	Indication	Phase
EXO‑CD24	Acute Respiratory Distress Syndrome (ARDS)	Phase 2

Leadership Team at Nano24med

Prof. Nadir Arber

Dr. Shiran Shapira

Prof. Jürgen Rockstroh

Prof. Neville Berkman

Dr. Gadi Ben‑Ari

View full Nano24med profile